Paloma Partners’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Paloma Partners’s Portfolio BIOS Stock Details BIOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-20,000	Closed	-$207K	–	1082
2022 Q4	$206K	Hold	20,000	–	–	0.01%	704
2022 Q3	$201K	Hold	20,000	–	–	0.01%	728
2022 Q2	$201K	Hold	20,000	–	–	0.01%	863
2022 Q1	$198K	Buy	+20,000	New	+$197K	0.01%	1425

Paloma Partners's BIOS Position: Q1 2023 in Review

Paloma Partners sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q1 2023, closing a stake of 20,000 shares — an estimated $207K sold.

Paloma Partners first reported a position in BIOS in Q1 2022 and held it in 4 quarters. The position peaked at $206K in Q4 2022. 61 funds tracked by Wall St. Rank hold BIOS as of Q1 2023.

Paloma Partners reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Paloma Partners sold 20,000 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q1 2023, an estimated $207K.
Paloma Partners first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q1 2022 and held it in 4 quarters.
Paloma Partners's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $206K in Q4 2022.
61 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q1 2023.

Based on Paloma Partners's 13F filing for Q1 2023, filed 15 May 2023.